GCB’s value proposition boils down to quality, velocity, and simplicity.

Quality. Benchtop and pilot-scale data is critical for achieving your technical and commercial goals. Maintaining world-class operational standards and delivering accurate and precise data packages is GCB’s top priority.

Velocity. Data and samples impact every facet of your business, including experimental design, customer engagement, and investor relations. GCB works with you to schedule batches when you need them, and GCB returns deliverables quickly.

Simplicity. GCB has a straightforward contracting structure in which you own your organism and your process, and you only pay for what you use. GCB makes it easy to get the data and samples that you need.

GCB’s clients are developing breakthrough products in a variety of industries, including alternative protein, biopharma, biofuels, personal care, industrials, and more.

GCB’s core offering includes R&D-grade samples and a robust data package.

Contact us to discuss the solution that is right for you.

GCB supports clients at all stages of development.

Whether you are trying to make your first grams of a new product, make an in-market product more profitable, or anything in between, GCB can help you achieve your business objectives.

GCB’s first facility is in Durham, North Carolina, USA.

In the heart of North Carolina’s Research Triangle, GCB is surrounded by world-class research universities, leading biopharma manufacturing facilities, and innovative startups. GCB is just minutes from RDU, a leading international airport.

GCB’s benchtop service helps you improve your upstream process via strain screening, media optimization, and fermentation condition optimization.

GCB will help you translate benchtop success to pilot success on one platform and under one roof.

At GCB, “benchtop scale” is 1L to 10L of working volume per batch.

GCB’s piloting service allows you to simulate commercial scale conditions quickly and cost-effectively.

GCB has carefully selected its pilot scale equipment, including a full downstream processing (DSP) suite, to be representative of commercial scale equipment.

At GCB, “pilot scale” is 100L of working volume per batch.

Precision fermentation uses microbes (such as yeast, bacteria, or filamentous fungi) as “cell factories” to produce target molecules in 3 primary steps:

1) Strain Engineering. Genetically modify the microbe’s DNA.

2) Fermentation. Grow the microbes in precise conditions.

3) Downstream Processing. Purify the fermentation broth to isolate the desired final product.

Precision fermentation has been used safely and successfully for decades.

The US Food and Drug Administration (FDA) approved human insulin made via precision fermentation in 1982. Additionally, several precision fermentation companies have established food products as safe under the FDA’s Generally Recognized as Safe (GRAS) program.